SA
Sign upLog In
ARWR

ARWR Goodwill & Intangibles

$5.59MQuarterly · USD

Period ending:

AnnualQuarterlyChart Studio →
ARWR FY Goodwill & IntangiblesUSD
ARWR FY Goodwill & Intangibles1997-09-30: $0.001998-09-30: $0.001999-09-30: $0.002000-09-30: $0.002001-09-30: $0.002002-09-30: $0.002003-09-30: $0.002004-09-30: $1.46M2005-09-30: $5.04M2006-09-30: $4.32M2007-09-30: $2.94M2008-09-30: $2.75M2009-09-30: $2.36M2010-09-30: $2.05M2011-09-30: $1.73M2012-09-30: $4.78M2013-09-30: $3.24M2014-09-30: $1.01M2015-09-30: $24.82M2016-09-30: $22.16M2017-09-30: $20.46M2018-09-30: $18.76M2019-09-30: $17.06M2020-09-30: $15.36M2021-09-30: $13.66M2022-09-30: $11.96M2023-09-30: $10.26M2024-09-30: $8.56M2025-09-30: $6.86M$24.82M$0.00
1997-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ARWR goodwill & intangibles history

Goodwill and intangible assets. The available annual fiscal periods series contains 29 observations from Sep 30, 1997 to Sep 30, 2025.

Arrowhead Pharmaceuticals Inc Goodwill & Intangibles — Annual fiscal periods (USD)
Period endingGoodwill & Intangibles (USD)
6,861,000
8,562,000
10,262,000
11,962,000
13,663,000
15,363,151
17,063,580
18,764,010
20,464,439
22,164,868
24,824,116
1,013,473
3,240,513
4,784,569
1,731,211
2,046,836
2,362,460
2,749,555
2,938,513
4,317,637
5,038,225
1,461,266
0
0
0
0
0
0
0

Compare goodwill & intangibles

All ARWR financial metrics · ARWR stock overview · How to interpret financial metrics

Explore More

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.